GTTIX | VTCAX | GTTIX / VTCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 20 years | - |
Gain YTD | 22.825 | 33.953 | 67% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 66.4M | 4.64B | 1% |
Annual Yield % from dividends | 0.30 | 0.94 | 32% |
Returns for 1 year | 24.77 | 34.06 | 73% |
Returns for 3 years | 3.79 | 15.65 | 24% |
Returns for 5 years | 20.67 | 67.64 | 31% |
Returns for 10 years | 6.36 | 84.08 | 8% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VEMRX | 93.97 | 0.64 | +0.69% |
Vanguard Emerging Mkts Stock Idx InsPlus | |||
RYCFX | 41.26 | 0.28 | +0.68% |
Rydex Biotechnology C | |||
MCGCX | 18.45 | 0.11 | +0.60% |
BlackRock Advantage Global Investor C | |||
WWSYX | 20.39 | 0.02 | +0.10% |
Westwood Quality SmallCap Fund Ultra | |||
GQIRX | 47.43 | N/A | N/A |
Goldman Sachs US Tax-Managed Eq Inv |